France Asthma Inhaler Device Market
France Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
Industry Developments
The France Asthma Inhaler Device Market is currently witnessing significant developments. The market has seen innovative product introductions, including smart inhalers that utilize digital health technology to enhance patient adherence and management of asthma symptoms. Companies like AstraZeneca and GlaxoSmithKline have been at the forefront of these advancements, integrating new technologies into their existing inhaler portfolios. In recent months, in September 2023, Teva Pharmaceutical Industries announced a collaboration with a leading digital health firm to enhance patient engagement through smart inhalation devices.In the realm of mergers and acquisitions, no significant deals have been reported recently among the major players in the French Asthma Inhaler Device Market. However, the overall market valuation has been positively impacted by the increasing prevalence of asthma in France, which has reportedly reached around 4 million patients as of early 2023. Companies such as Sanofi and Novartis are focusing on expanding their market reach through Research and Development initiatives, aimed at producing more personalized inhalation therapies. These trends reflect a dynamic market landscape, responding proactively to the evolving needs of asthma patients in France.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 58.8(USD Million) |
| MARKET SIZE 2024 | 64.68(USD Million) |
| MARKET SIZE 2035 | 112.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.118% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, Mylan, Novartis, Sanofi, Merck KGaA, Havard Bioscience, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, AstraZeneca, Allergan |
| SEGMENTS COVERED | Type, Mode of Operation, End User |
| KEY MARKET OPPORTUNITIES | Innovative digital inhaler solutions, Increased demand for smart devices, Growing prevalence of asthma, Expansion of telehealth services, Rising awareness about asthma management |
| KEY MARKET DYNAMICS | rising asthma prevalence, increasing healthcare expenditure, technological advancements, government initiatives, growing awareness of respiratory health |
| COUNTRIES COVERED | France |
FAQs
What is the market size of the France Asthma Inhaler Device Market in 2024?
The France Asthma Inhaler Device Market is expected to be valued at 64.68 million USD in 2024.
What is the projected market size for the France Asthma Inhaler Device Market in 2035?
The market is projected to reach 112.0 million USD by the year 2035.
What is the expected compound annual growth rate (CAGR) for the France Asthma Inhaler Device Market from 2025 to 2035?
The expected CAGR for the market is 5.118% during the forecast period from 2025 to 2035.
Which type of inhalers is expected to dominate the market share in 2024?
Metered Dose Inhalers are expected to dominate the market with a valuation of 28.0 million USD in 2024.
What is the market value of Dry Powder Inhalers in 2035?
The market value of Dry Powder Inhalers is expected to reach 40.0 million USD by 2035.
Who are the key players in the France Asthma Inhaler Device Market?
Major players in the market include Pfizer, GlaxoSmithKline, Roche, and AstraZeneca among others.
What is the market value for Soft Mist Inhalers in 2024?
Soft Mist Inhalers are valued at 12.68 million USD in the year 2024.
What are the growth drivers for the France Asthma Inhaler Device Market?
Growth drivers include increasing prevalence of asthma, advancements in inhaler technology, and rising awareness among patients.
What has been the impact of the current global scenario on the France Asthma Inhaler Device Market?
Current global scenarios and conflicts may influence supply chains and pricing within the France Asthma Inhaler Device Market.
What is the expected market growth rate for Metered Dose Inhalers during the forecast period?
Metered Dose Inhalers are anticipated to see significant growth as they are projected to reach a market value of 46.0 million USD in 2035.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment